Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Comparison of the effectiveness of antibody and cell-mediated immunity against inhaled and instilled influenza virus challenge.

Rivers K, Bowen LE, Gao J, Yang K, Trombley JE, Bohannon JK, Eichelberger MC.

Virol J. 2013 Jun 19;10:198. doi: 10.1186/1743-422X-10-198.

PMID:
23777453
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Development of a murine nose-only inhalation model of influenza: comparison of disease caused by instilled and inhaled A/PR/8/34.

Bowen LE, Rivers K, Trombley JE, Bohannon JK, Li SX, Boydston JA, Eichelberger MC.

Front Cell Infect Microbiol. 2012 May 30;2:74. doi: 10.3389/fcimb.2012.00074. eCollection 2012.

PMID:
22919665
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.

Wang D, Christopher ME, Nagata LP, Zabielski MA, Li H, Wong JP, Samuel J.

J Clin Virol. 2004 Dec;31 Suppl 1:S99-106.

PMID:
15567101
[PubMed - indexed for MEDLINE]
4.

Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.

Soboleski MR, Gabbard JD, Price GE, Misplon JA, Lo CY, Perez DR, Ye J, Tompkins SM, Epstein SL.

PLoS One. 2011;6(7):e21937. doi: 10.1371/journal.pone.0021937. Epub 2011 Jul 15.

PMID:
21789196
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.

Chang H, Huang C, Wu J, Fang F, Zhang W, Wang F, Chen Z.

Virol J. 2010 Aug 21;7:197. doi: 10.1186/1743-422X-7-197.

PMID:
20727202
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A DNA vaccine-encoded nucleoprotein of influenza virus fails to induce cellular immune responses in a diabetic mouse model.

Jamali A, Sabahi F, Bamdad T, Hashemi H, Mahboudi F, Kheiri MT.

Clin Vaccine Immunol. 2010 Apr;17(4):683-7. doi: 10.1128/CVI.00445-09. Epub 2010 Feb 17.

PMID:
20164252
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.

Chen Z, Matsuo K, Asanuma H, Takahashi H, Iwasaki T, Suzuki Y, Aizawa C, Kurata T, Tamura S.

Vaccine. 1999 Feb 26;17(7-8):653-9.

PMID:
10067670
[PubMed - indexed for MEDLINE]
8.

Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.

Straight TM, Ottolini MG, Prince GA, Eichelberger MC.

Virol J. 2008 Mar 20;5:44. doi: 10.1186/1743-422X-5-44.

PMID:
18355405
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.

Staneková Z, Király J, Stropkovská A, Mikušková T, Mucha V, Kostolanský F, Varečková E.

Acta Virol. 2011;55(1):61-7.

PMID:
21434706
[PubMed - indexed for MEDLINE]
10.

Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus.

Rajesh Kumar S, Syed Khader SM, Kiener TK, Szyporta M, Kwang J.

PLoS One. 2013 Jun 7;8(6):e63856. doi: 10.1371/journal.pone.0063856. Print 2013.

PMID:
23762234
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice.

Huang B, Wang W, Li R, Wang X, Jiang T, Qi X, Gao Y, Tan W, Ruan L.

Virol J. 2012 Dec 29;9:322. doi: 10.1186/1743-422X-9-322.

PMID:
23272943
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.

Patel A, Gray M, Li Y, Kobasa D, Yao X, Kobinger GP.

Vaccine. 2012 Jan 11;30(3):626-36. doi: 10.1016/j.vaccine.2011.11.017. Epub 2011 Nov 23.

PMID:
22119588
[PubMed - indexed for MEDLINE]
13.

Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.

de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.

Vaccine. 2012 Jul 6;30(32):4884-91. doi: 10.1016/j.vaccine.2012.04.032. Epub 2012 Apr 23.

PMID:
22537989
[PubMed - indexed for MEDLINE]
14.

[Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].

Huang BY, Wang XP, Wang WL, Hu W, Gao Q, Tan WJ, Ruan L.

Bing Du Xue Bao. 2011 May;27(3):265-73. Chinese.

PMID:
21774253
[PubMed - indexed for MEDLINE]
15.

Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin.

Alexander J, Ward S, Mendy J, Manayani DJ, Farness P, Avanzini JB, Guenther B, Garduno F, Jow L, Snarsky V, Ishioka G, Dong X, Vang L, Newman MJ, Mayall T.

PLoS One. 2012;7(2):e31177. doi: 10.1371/journal.pone.0031177. Epub 2012 Feb 17.

PMID:
22363572
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.

Galarza JM, Latham T, Cupo A.

Viral Immunol. 2005;18(2):365-72.

PMID:
16035948
[PubMed - indexed for MEDLINE]
17.

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.

Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM.

Arch Virol. 2006 May;151(5):921-31. Epub 2005 Nov 15.

PMID:
16292596
[PubMed - indexed for MEDLINE]
18.

Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.

Galarza JM, Latham T, Cupo A.

Viral Immunol. 2005;18(1):244-51.

PMID:
15802970
[PubMed - indexed for MEDLINE]
19.

Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.

Tamura S, Funato H, Hirabayashi Y, Suzuki Y, Nagamine T, Aizawa C, Kurata T.

Eur J Immunol. 1991 Jun;21(6):1337-44.

PMID:
1646112
[PubMed - indexed for MEDLINE]
20.

Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.

Weaver EA, Rubrum AM, Webby RJ, Barry MA.

PLoS One. 2011 Mar 28;6(3):e18314. doi: 10.1371/journal.pone.0018314.

PMID:
21464940
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk